User:Mr. Ibrahem/Uridine triacetate

Uridine triacetate, formerly known as vistonuridine, is a medication used to treat hereditary orotic aciduria and poisoning due to fluorouracil or capecitabine. For poisoning it should be used within 4 days and in an overdose may be used regardless of the presence of symptoms. It is taken by mouth.

Side effects may include nausea or diarrhea. Use in pregnancy and breastfeeding is of unclear safety. It is a prodrug of uridine; by which it acts.

Uridine triacetate was approved for medical use in the United States in 2015. It is not approved in Europe. In the United States it costs about 4,200 USD per 10 gram dose as of 2021. In the United States it is only available through specialty pharmacies. In Canada approval is required from the Health Canada Special Access Programme. Brand names include Vistogard and Xuriden.